vimarsana.com

Page 15 - அதிகபட்சம் அருமை சிறப்பு மருத்துவமனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19 recovered people showing faster antibody response to Serum Institute vaccine Covishield, says study

COVID-19 recovered people showing faster antibody response to Serum Institute vaccine Covishield, says study
medicaldialogues.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicaldialogues.in Daily Mail and Mail on Sunday newspapers.

People Who Recovered From Covid-19 Show Faster Antibody Response To Covishield Vaccine: Study

Covishield vaccine:: COVID-19 recovered people showing faster antibody response to Covishield vaccine: Study

Synopsis The study on the immune response to Covishield was carried out by researchers from New Delhi s CSIR-Institute of Genomics and Integrative Biology (IGIB), Max Super Speciality Hospital and Institute of Endocrinology, Diabetes and Metabolism as well as the Academy of Scientific and Innovative Research (AcSIR) in Ghaziabad. PTI Those who have recovered from COVID-19 respond faster to the Covishield vaccine and reach high antibody levels, says a study, leading to hopes that they may not need a second dose and therefore help widen India s corona immunisation cover. The study on the immune response to Covishield was carried out by researchers from New Delhi s CSIR-Institute of Genomics and Integrative Biology (IGIB), Max Super Speciality Hospital and Institute of Endocrinology, Diabetes and Metabolism as well as the Academy of Scientific and Innovative Research (AcSIR) in Ghaziabad.

Govt allows 24X7 vaccination; Covaxin shows 81% interim efficacy | 10 points on Covid vaccines

Govt allows 24x7 vaccination; Covaxin shows 81% interim efficacy | 10 points on Covid vaccines The govt has allowed hospitals to carry out Covid-19 vaccination round-the-clock in order to speed-up the vaccination drive. Meanwhile, results of Phase 3 trials of Covaxin show it demonstrates 81 per cent interim efficacy. advertisement Bharat Biotech announced interim results of Phase 3 trials of Covaxin on Wednesday. (Photo: PTI) In a boost to India s nationwide Covid-19 vaccination drive, Bharat Biotech on Wednesday announced that interim analysis of Phase 3 clinical trials of its Covid-19 vaccine candidate, Covaxin, show the vaccine demonstrates 81 per cent interim efficacy. Meanwhile, to speed up the vaccination drive, the central government has now allowed all private hospitals to administer Covid-19 vaccines. It has also done away with the 9am to 5pm time limit for vaccination. Now, hospitals are free to carry out 24X7 vaccination.

Covid-19 recovered people showing faster antibody response to Covishield vaccine: Study | India News

Covid-19 recovered people showing faster antibody response to Covishield vaccine: Study | India News
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.